Abstract:The HIV-Ι trans-activation responsive (TAR) RNA–trans-activator of transcription (Tat) protein complex is crucial for the efficient transcription of the integrated human immunodeficiency virus-I genome and is an established therapeutic target for AIDS diagnosis and treatment. Developing a sensitive strategy for the TAR RNA-binding ligand assay could provide antiviral leads with a radically new mechanism for the treatment of AIDS. Herein, a new TAR RNA-binding ligand assay platform was established using a signal amplification strategy that combines aggregation-induced emission (AIE) with a metal-enhanced fluorescence (MEF) concept. The tetraphenylethylene (TPE) derivative was labeled on the Tat peptide as a fluorescent molecule, while the TAR RNA was immobilized on the surface of the Fe3O4@@SiO2 nanoparticles (NPs) to specifically bind the TPE-Tat peptide. The TPE-Tat peptide was weakly emissive itself while emitting strongly in the NP–TAR–TPE-Tat complex by the AIE and MEF signal amplification effect. It was confirmed by known Tat peptide competitors that this system could be applied to the screening and detection of TAR RNA-binding ligands because they could replace the TPE-Tat peptide from the complex and make the system fluorescence decrease. When this system was adopted to test four candidate ligands, it was found that bisantrene had a favorable TAR RNA-binding ability. The proposed AIE–MEF strategy not only provides a sensitive and reliable method for the TAR RNA-binding ligand assay but also can avoid the influence of ligands on fluorescent detection in the conventional displacement assay.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.analchem.1c04889.Synthesize of the Fe3O4@@SiO2–TAR RNA NPs; TEM images of Fe3O4, Fe3O4@Au, Fe3O4@, and Fe3O4@@SiO2 NPs at the silica shell thicknesses of 10.9, 13.9, 17.9, and 30.8 nm; UV–vis spectra of the Fe3O4@ NPs with various volumes of Ag sources and the Fe3O4@@SiO2 NPs with different SiO2 thickness; UV–vis absorption spectrum of the Fe3O4@@SiO2 NPs and the emission spectrum of TPE-Tat; hysteresis cycle diagram of the Fe3O4 and Fe3O4@@SiO2 NPs; FI of the AIE–MEF system in the presence of different concentrations of neomycin B, mitoxantrone, and chlorpromazine; effect of the small ligands on the fluorescence of the TAR–FITC-Tat system and the FITC-Tat; structural formula of all the ligands studied in this work; UV–vis absorption spectra of the studied ligands and the fluorescence emission spectra of TPE and ICR-191 molecules; and comparison of the LOD obtained in this work for three ligands with the literature (PDF)This article has not yet been cited by other publications.

Studies of binding constants and interaction of drugs to -activation response RNA by capillary electrophoresis

Study On The Interaction Of Human Immunodeficiency Virus Inhibitor, Trans-Activitor Of Transcription Protein And Ribonucleic Acid System By Capillary Electrophoresis

Study on the Interactions Between Anti-Hiv-1 Active Compounds with Trans-Activation Response RNA by Affinity Capillary Electrophoresis

Capillary Zone Electrophoretic Separation of Four Novel Compounds Active Against Human Immunodeficiency Virus Type 1

HIV-1 Transcription Inhibition Using Small RNA-Binding Molecules.

The TAR Binding Dynamics and Its Implication in Tat Degradation Mechanism

Co-crystal structures of HIV TAR RNA bound to lab-evolved proteins show key roles for arginine relevant to the design of cyclic peptide TAR inhibitors

TAR RNA selective targeting ruthenium(II) complexes as HIV-1 reverse transcriptase inhibitors: On exploring structure-activity relationships of multiple positions

Solid-phase Synthesis and Evaluation of TAR RNA Targeted Beta-Carboline-nucleoside Conjugates.

Structure-guided optimization of small molecules inhibiting human immunodeficiency virus 1 Tat association with the human coactivator p300/CREB binding protein-associated factor.

Identification of inhibitors of the HIV-1 gp41 six-helix bundle formation from extracts of Chinese medicinal herbs Prunella vulgaris and Rhizoma cibotte.

Alpha,Alpha-Trehalose Derivatives Bearing Guanidino Groups As Inhibitors to Hiv-1 Tat-Tar Rna Interaction in Human Cells

Aqueous solution structure of a hybrid lentiviral Tat peptide and a model of its interaction with HIV-1 TAR RNA

Terpyridyl ruthenium complexes as visible spectral probe for poly(A) RNA and bifunctional TAR RNA binders and HIV-1 reverse transcriptase inhibitors

[Determination of the Binding Constants of Four Anti-Hiv-1 Active Compounds with Bovine Serum Albumin by Capillary Zone Electrophoresis].

Metal-Enhanced Aggregation-Induced Emission Strategy for the HIV-I RNA-Binding Ligand Assay

Identifying the Molecular Mechanics and Binding Dynamics Characteristics of Potent Inhibitors to HIV‐1 Protease

Ligand-RNA Interaction Assay Based on Size-Selective Fluorescence Core-Shell Nanocomposite.

Enzyme Hinders HIV-1 Tat Viral Transport and Real-Time Measured with Nanopores

Insights into the Structural Function of the Complex of HIV-1 Protease with TMC-126: Molecular Dynamics Simulations and Free-Energy Calculations

Identification of novel CDK9 and Cyclin T1-associated protein complexes (CCAPs) whose siRNA depletion enhances HIV-1 Tat function